Novel Augmentation Strategies in Major Depression

Medicine & Life Sciences

• Antidepressive Agents 27%
• Bipolar Disorder 11%
• Depression 100%
• Depressive Disorder 6%
• Desvenlafaxine Succinate 20%
• Diagnostic and Statistical Manual of Mental Disorders 5%
• Diaries 6%
• Duloxetine Hydrochloride 25%
• Equipment and Supplies 3%
• Exercise 59%
• General Practitioners 5%
• Hydrocortisone 59%
• Inpatients 4%
• Light 68%
• Mental Health 4%
• Patient Selection 5%
• Phototherapy 58%
• Pindolol 85%
• Placebos 4%
• Psychiatry 18%
• Publications 5%
• Quality of Life 3%
• Randomized Controlled Trials 4%
• Saliva 17%
• Self-Assessment 13%
• Sertraline 32%
• Sleep 56%
• Survival Analysis 5%
• Tablets 5%
• Therapeutics 18%
• Thyroid Gland 5%
• Urine 4%
• Venlafaxine Hydrochloride 32%